Meyka AI API is live for developers.Start building.
Advertisement
Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc. (RKTO) Stock Overview

Explore Hoth Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RKTONASDAQ
HealthcareMedical - Pharmaceuticals
$1.51
$0.46(23.35%)
U.S. Market opens in 49h 42m
Advertisement

Hoth Therapeutics, Inc. (RKTO)

Meyka AI Score

Z

Key Financials

Market Cap31.5M
P/E Ratio-1.97
EPS (TTM)$-0.90
ROE-1.65%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

RKTO Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hoth Therapeutics, Inc. (RKTO) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 47.27, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.97 and a market capitalization of 31.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-23.86%
5-Day Change
N/A
1-Month Change
111.27%
3-Month Change
48.51%
6-Month Change
25.00%
Year-to-Date (YTD) Change
51.52%
1-Year Change
23.97%
3-Year Change
-20.21%
5-Year Change
-96.57%
All-Time (Max) Change
-99.30%

Contact Information

NaN
NaN, Hoboken, NaN, NaN

Company Facts

6 Employees
CountryUS
Actively Trading

Frequently Asked Questions